The support that Dementias Platform UK offers, in terms of improving the data available to researchers for use in clinical trials, does not stop there. To find further developments in dementia research, Anna Myers, from the University of Oxford, Oxford, UK, highlights the importance of working together with universities, pharmaceutical companies and smaller organizations. Recorded at the Alzheimer’s Research UK (ARUK) Conference 2018, held in London, UK.